Antisense RNA directed to the human papillomavirus type 16 E7 mRNA from herpes simplex virus type 1 derived vectors

Ilkka Kari1, Stina Syrjänen, Bo Johansson

  • 1Department of Virology, Institute of Dentistry, University of Turku, Turku, Finland. ilanka@utu.fi

Virology Journal
|June 6, 2007
PubMed
Abstract

Insights

Herpes simplex virus (HSV) vectors expressing antisense RNA effectively reduced human papillomavirus (HPV) oncogene E7 mRNA and protein in cervical cancer cells. This suggests HSV vectors show promise for HPV gene therapy.

Area of Science:

  • Oncology
  • Virology
  • Gene Therapy

Background:

  • Human papillomavirus (HPV) is a primary cause of cervical cancer.
  • Current treatments lack HPV-specific therapies for invasive cervical cancer and precursor lesions.

Purpose of the Study:

  • To investigate the potential of herpes simplex virus (HSV) vectors for expressing antisense RNA targeting the HPV-16 E7 oncogene.

Main Methods:

  • Constructed replication-competent, nonneuroinvasive HSV-1 vectors lacking the gamma134.5 gene.
  • Vectors expressed RNA antisense to the HPV-16 E7 gene's initial 100 nucleotides.
  • Assayed E7 mRNA and protein downregulation in HPV-16 positive CaSki cells using R5225 (tk-) and R5226 (tk+) vectors.

Main Results:

  • Both HSV vectors successfully produced antisense E7 RNA in a dose-dependent manner.
  • Expression of HPV-16 E7 mRNA was significantly downregulated in CaSki cells infected with R5225 or R5226.
  • The tk+ recombinant vector (R5226) effectively downregulated E7 protein expression.

Conclusions:

  • Antisense RNA delivered via HSV vectors efficiently reduced HPV-16 E7 mRNA and protein levels in CaSki cells.
  • HSV vectors represent a potential therapeutic tool for gene therapy targeting HPV infections.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...